Binding of plasminogen activators to fibrin: characterization and pharmacological consequences.
作者信息
Fears R
机构信息
Beecham Pharmaceuticals Research Division, Epsom, Surrey, U.K.
出版信息
Biochem J. 1989 Jul 15;261(2):313-24. doi: 10.1042/bj2610313.
Abstract
摘要
相似文献
1
Binding of plasminogen activators to fibrin: characterization and pharmacological consequences.纤溶酶原激活剂与纤维蛋白的结合：特性及药理学后果
Biochem J. 1989 Jul 15;261(2):313-24. doi: 10.1042/bj2610313.
2
Interaction of plasminogen activators and inhibitors with plasminogen and fibrin.纤溶酶原激活剂和抑制剂与纤溶酶原及纤维蛋白的相互作用。
Semin Thromb Hemost. 1982 Jan;8(1):2-10. doi: 10.1055/s-2007-1005038.
3
Staplabin, a novel fungal triprenyl phenol which stimulates the binding of plasminogen to fibrin and U937 cells.斯他拉宾，一种新型真菌三萜酚，可刺激纤溶酶原与纤维蛋白及U937细胞的结合。
J Antibiot (Tokyo). 1996 Oct;49(10):961-6. doi: 10.7164/antibiotics.49.961.
4
Kinetic studies on the interaction of streptokinase and other plasminogen activators with plasminogen and fibrin.链激酶及其他纤溶酶原激活剂与纤溶酶原和纤维蛋白相互作用的动力学研究。
Biochem J. 1985 Jul 15;229(2):555-8. doi: 10.1042/bj2290555.
5
Plasminogen activators: pharmacology and therapy.纤溶酶原激活剂：药理学与治疗学
Radiology. 1990 Mar;174(3 Pt 2):993-1001. doi: 10.1148/radiology.174.3.174-3-993.
6
[Studies on a plasminogen activating system in human milk: IV. Difference in the binding to fibrin between human milk plasminogen activator (mild activator) and urokinase (author's transl)].
Nihon Ketsueki Gakkai Zasshi. 1979 Oct;42(5):38-45.
7
Dysfibrinogenemia (fibrinogen Dusard) associated with impaired fibrin-enhanced plasminogen activation.异常纤维蛋白原血症（杜萨尔纤维蛋白原）与纤维蛋白增强的纤溶酶原激活受损有关。
Thromb Haemost. 1984 Feb 28;51(1):108-9.
8
Fibrin binding and zymogenic properties of single-chain urokinase (pro-urokinase).
Semin Thromb Hemost. 1987 Apr;13(2):146-51. doi: 10.1055/s-2007-1003485.
9
Clot penetration and retention by plasminogen activators promote fibrinolysis.纤溶酶原激活物促进血栓穿透和滞留，从而促进纤维蛋白溶解。
Biochem Pharmacol. 2013 Jan 15;85(2):216-22. doi: 10.1016/j.bcp.2012.10.011. Epub 2012 Oct 23.
10
[Tissue plasminogen activator: a new thrombolytic specific t fibrin].
Nouv Rev Fr Hematol (1978). 1985;27(1):3-4.
引用本文的文献
1
Inner clot diffusion and permeation during fibrinolysis.纤维蛋白溶解过程中的内部凝块扩散与渗透。
Biophys J. 1993 Dec;65(6):2622-43. doi: 10.1016/S0006-3495(93)81314-6.
2
Tissue plasminogen activator (tPA) inhibits plasmin degradation of fibrin. A mechanism that slows tPA-mediated fibrinolysis but does not require alpha 2-antiplasmin or leakage of intrinsic plasminogen.组织型纤溶酶原激活剂（tPA）抑制纤溶酶对纤维蛋白的降解。该机制可减缓tPA介导的纤维蛋白溶解，但不需要α2-抗纤溶酶或内源性纤溶酶原的泄漏。
J Clin Invest. 1995 Jun;95(6):2483-90. doi: 10.1172/JCI117949.
3
A recombinant chimeric plasminogen activator with high affinity for fibrin has increased thrombolytic potency in vitro and in vivo.一种对纤维蛋白具有高亲和力的重组嵌合纤溶酶原激活剂在体外和体内均具有增强的溶栓效力。
Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10337-41. doi: 10.1073/pnas.88.22.10337.
4
Soluble fibrin preparations inhibit the reaction of plasmin with alpha 2-macroglobulin. Comparison with alpha 2-antiplasmin and leupeptin.可溶性纤维蛋白制剂可抑制纤溶酶与α2-巨球蛋白的反应。与α2-抗纤溶酶和亮抑酶肽的比较。
Biochem J. 1991 Apr 1;275 ( Pt 1)(Pt 1):53-9. doi: 10.1042/bj2750053.
5
Stimulation of plasmin activity by oleic acid.油酸对纤溶酶活性的刺激作用。
Biochem J. 1992 Mar 15;282 ( Pt 3)(Pt 3):863-6. doi: 10.1042/bj2820863.
本文引用的文献
1
The effectiveness of activators in clot lysis, with special reference to fibrinolytic therapy. A new method for determination of preformed clot lysis.
Acta Med Scand Suppl. 1962;386:1-24. doi: 10.1111/j.0954-6820.1962.tb03046.x.
2
The mechanism of clot dissolution by plasmin.纤溶酶溶解血栓的机制。
J Clin Invest. 1959 Jul;38(7):1086-95. doi: 10.1172/JCI103885.
3
Morphology of bovine fibrinogen monomers and fibrin oligomers.牛纤维蛋白原单体和纤维蛋白寡聚体的形态学
J Mol Biol. 1981 Aug 15;150(3):399-408. doi: 10.1016/0022-2836(81)90555-6.
4
Fibrinolysis with acyl-enzymes: a new approach to thrombolytic therapy.酰基酶介导的纤维蛋白溶解：溶栓治疗的新方法。
Nature. 1981 Apr 9;290(5806):505-8. doi: 10.1038/290505a0.
5
An enhancing effect of poly-lysine on the activation of plasminogen.聚赖氨酸对纤溶酶原激活的增强作用。
Thromb Haemost. 1982 Feb 26;47(1):41-5.
6
Fibrinolytic properties of one-chain and two-chain human extrinsic (tissue-type) plasminogen activator.单链和双链人外源性（组织型）纤溶酶原激活剂的纤维蛋白溶解特性
J Biol Chem. 1982 Mar 25;257(6):2920-5.
7
Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin.人组织型纤溶酶原激活物激活纤溶酶原的动力学。纤维蛋白的作用。
J Biol Chem. 1982 Mar 25;257(6):2912-9.
8
The binding of human plasminogen to fibrin and fibrinogen.人纤溶酶原与纤维蛋白及纤维蛋白原的结合。
J Biol Chem. 1983 Apr 10;258(7):4249-56.
9
The binding of plasminogen to fibrin: evidence for plasminogen-bridging.纤溶酶原与纤维蛋白的结合：纤溶酶原桥接的证据。
Thromb Res. 1982 Aug 1;27(3):311-20. doi: 10.1016/0049-3848(82)90078-0.
10
Common evolutionary origin of the fibrin-binding structures of fibronectin and tissue-type plasminogen activator.纤连蛋白和组织型纤溶酶原激活物的纤维蛋白结合结构的共同进化起源。
FEBS Lett. 1983 Oct 31;163(1):37-41. doi: 10.1016/0014-5793(83)81157-0.
Zotero 插件